OPTN scrutiny continues. For the first time, HHS will decertify an organ procurement organization midcycle in response to allegations of unsafe practices and chronic underperformance. The OPTN board of directors will also designate an OPTN patient safety director, and each organ procurement organization will appoint an OPTN patient safety officer. In a press conference, HHS also announced significant investments in programs for living donors and research to find alternatives to organ donation.